Sign in

CIK 0001048477

  • Large accelerated filer

BIOMARIN PHARMACEUTICAL INC

Sign in to watch
Ticker
BMRN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
680397820
Phone
+1 415-506-6700
Business address
105 DIGITAL DRIVE, NOVATO, CA, 94949
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,163,748
in 1 filing

Net −$1,163,748. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Davis George Eric −$1.2M EVP, Chief Legal Officer sold 22% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-05-09 BIENAIME JEAN JACQUES Chief Executive Officer Sale 10b5-1 −13,626 $94.22 $1.3M 442,587
2023-05-09 BIENAIME JEAN JACQUES Chief Executive Officer Sale 10b5-1 −14,964 $95.49 $1.4M 427,623
2023-05-09 BIENAIME JEAN JACQUES Chief Executive Officer Sale 10b5-1 −1,410 $95.90 $135K 426,213
2023-05-09 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy Common Stock) 10b5-1 −30,000 99,130
2023-05-09 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy Common Stock) 10b5-1 −30,000 69,130
2023-05-04 Guyer Charles Greg EVP, Chief Technical Officer Shares withheld for taxes −4,302 $95.45 $411K 45,401
2023-04-28 FUCHS HENRY J President, Worldwide R&D Grant or award +317 $66.88 $21K 176,504
2023-04-28 Ajer Jeffrey Robert EVP, Chief Commercial Officer Grant or award 10b5-1 +318 $66.88 $21K 65,804
2023-04-28 Davis George Eric EVP, Chief Legal Officer Grant or award +317 $66.88 $21K 80,684
2023-04-28 BIENAIME JEAN JACQUES Chief Executive Officer Grant or award 10b5-1 +317 $66.88 $21K 426,213
2023-04-28 Guyer Charles Greg EVP, Chief Technical Officer Grant or award +239 $66.88 $16K 49,703
2023-04-10 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion 10b5-1 +10,000 $67.81 $678K 435,896
2023-04-10 BIENAIME JEAN JACQUES Chief Executive Officer Sale 10b5-1 −10,000 $99.56 $996K 425,896
2023-04-10 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy Common Stock) 10b5-1 −10,000 129,130
2023-04-06 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion 10b5-1 +10,000 $67.81 $678K 435,896
2023-04-06 BIENAIME JEAN JACQUES Chief Executive Officer Sale 10b5-1 −10,000 $96.13 $961K 425,896
2023-04-06 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy Common Stock) 10b5-1 −10,000 139,130
2023-04-03 LAWLIS V BRYAN Director Exercise or conversion 10b5-1 +8,500 $67.81 $576K 37,450
2023-04-03 LAWLIS V BRYAN Director Sale 10b5-1 −8,500 $97.09 $825K 28,950
2023-04-03 LAWLIS V BRYAN Director Exercise or conversion · Stock Option (Right to Buy Common Stock) 10b5-1 −8,500 0

Page 15 of 23 · 450 trades